4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-20-052116
CMO and Head of R&D acquired 668,745 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PRASAD SUYASH CMO and Head of R&D | 2020-09-23 | Grant or award | +668,745 | 668,745 | D |
Loading xslF345X03/doc4.xml…